Your Patient Can't Find Cyclosporine — What Can You Do?

A patient calls your office in a panic: their pharmacy says Cyclosporine is out of stock, and they're running low. For transplant patients, this is a potential emergency. For autoimmune patients, it's a path toward a flare that could set back months of progress. As a provider, you're in a unique position to help — but only if you have a plan.

This guide walks through practical steps you can take when patients can't find Cyclosporine, including real-time search tools, alternative strategies, and workflow changes that prevent these situations from becoming crises.

Current Cyclosporine Availability

As of early 2026, here's the supply picture:

• Modified oral capsules (Neoral, Gengraf, generics): Generally available but with intermittent shortages at certain pharmacies and with certain generic manufacturers.
• Non-modified oral capsules (Sandimmune): Available but less commonly stocked, as most prescribers have transitioned to modified formulations.
• Oral solution (100 mg/mL): Available. Supply stabilized after the 2024 Novartis recall of two Sandimmune oral solution lots.
• Injection (50 mg/mL): Permanently discontinued as of January 2024.
• Ophthalmic (Restasis, Cequa, Vevye): Available without shortage.

For a comprehensive supply update, review our provider shortage briefing.

Why Patients Can't Find Cyclosporine

Understanding the root causes helps you set realistic expectations with patients:

1. Limited generic competition: Cyclosporine's narrow therapeutic index (NTI) designation makes generic manufacturing more complex and regulated, resulting in fewer manufacturers.
2. Supply chain consolidation: Chain pharmacies often use centralized distribution, so when a wholesaler runs low, entire regions can be affected simultaneously.
3. Formulation complexity: Cyclosporine is derived from a fungal metabolite and requires specialized manufacturing. Quality issues (like the 2024 crystallization recall) can remove inventory suddenly.
4. Increased oral demand: The 2024 discontinuation of Cyclosporine Injection shifted more patients to oral formulations, straining the existing oral supply.

What Providers Can Do: 5 Steps

Step 1: Search Real-Time Pharmacy Inventory with Medfinder

Medfinder for Providers allows your staff to search for Cyclosporine stock at pharmacies near a patient's location. This is faster than having the patient call pharmacies individually and gives you actionable data to direct them to a specific location with confirmed availability.

Use cases:

• Transplant discharge planning — ensure the patient can fill their prescription before leaving the hospital
• Urgent refills — quickly locate a pharmacy that has stock today
• Cross-checking — verify that the pharmacy you're sending a new prescription to actually has the medication

Step 2: Prescribe by Generic Name with Formulation Specified

Writing "Cyclosporine modified capsules" rather than a specific brand increases the pharmacy's flexibility to fill from available manufacturers. However, always specify modified vs. non-modified — these are not interchangeable.

Consider including on the prescription:

• Generic name: Cyclosporine (modified)
• Strength and quantity
• "May substitute generic" or "DAW 0" to allow pharmacist flexibility
• A note: "Modified formulation required — do not substitute non-modified (Sandimmune)"

Step 3: Establish Relationships with Specialty Pharmacies

Specialty pharmacies that focus on transplant and immunology medications typically maintain larger, more reliable Cyclosporine inventories than retail chains. Consider:

• Identifying 2-3 specialty pharmacies in your area or nationally that ship
• Setting up prescriber accounts for faster processing
• Including specialty pharmacy options in your transplant or autoimmune patient onboarding materials

Step 4: Maintain Documented Alternative Regimens

For each Cyclosporine-dependent patient, consider documenting a pre-approved alternative plan in their chart:

• For transplant patients: Tacrolimus (Prograf) is the most common direct substitute. Document the estimated conversion dose and monitoring plan. Standard protocol: discontinue Cyclosporine, wait 12-24 hours, initiate Tacrolimus, monitor troughs.
• For psoriasis patients: Methotrexate, Apremilast (Otezla), or biologics (Secukinumab, Guselkumab) may be appropriate depending on disease severity.
• For rheumatoid arthritis: Methotrexate remains first-line. Biologics (Adalimumab, Etanercept) or JAK inhibitors (Tofacitinib) are alternatives for refractory disease.
• For nephrotic syndrome: Tacrolimus, with monitoring. Rituximab for refractory cases (off-label).

Having this documented means you can act quickly when a patient calls about a stock-out rather than starting the decision process from scratch. For a patient-facing version, see alternatives to Cyclosporine.

Step 5: Help Patients with Cost Barriers

Sometimes "can't find" really means "can't afford." Ensure patients know about:

• Discount cards: GoodRx and SingleCare bring generic Cyclosporine modified capsules to ~$43-$80/month
• Novartis $0 Co-Pay Card: For commercially insured patients on Neoral or Sandimmune (saveonmyprescription.com)
• Novartis Patient Assistance Foundation: Free medication for eligible uninsured patients (pap.novartis.com)
• NeedyMeds and RxAssist: Databases of patient assistance programs

For comprehensive cost guidance, see our provider resource on helping patients save money on Cyclosporine.

Workflow Tips for Your Practice

Proactive workflows prevent emergencies:

• Early refill alerts: Set up your EHR to flag patients who are within 14 days of running out of Cyclosporine. This gives adequate buffer time to locate stock.
• Pharmacy verification at discharge: Before discharging transplant patients, have nursing or pharmacy staff confirm Cyclosporine is in stock at the patient's pharmacy of choice using Medfinder.
• Patient education handout: Create a one-page resource for patients explaining what to do if their pharmacy is out — including Medfinder, independent pharmacy options, and when to call your office.
• Document the formulation: In every Cyclosporine patient's chart, clearly note whether they're on modified or non-modified and which brand/generic they've been stable on. This prevents accidental formulation switches during refills.

Final Thoughts

Cyclosporine supply disruptions are a reality that prescribers across specialties must manage. By incorporating real-time tools like Medfinder, building relationships with specialty pharmacies, and maintaining documented alternative plans for each patient, you can turn a potential crisis into a manageable inconvenience.

The most effective intervention is proactive: don't wait for the panicked phone call. Build systems that catch supply problems before your patients run out.